Moreover, experimental validation was conducted to further confirm the higher expression of MDK, a key gene in HCC, thus providing a potential biomarker for diagnosis and a therapeutic target for clinical research and therapy. This evidence concerns the gene MDK and hepatocellular carcinoma.